CLINICAL_TRIALS
trial_result
· 2017-10-23
Clinical Trial Update: Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia [Phase 2]
Summary
A Phase 2 trial studying mini-dose glucagon for treating non-severe hypoglycemia in Type 1 diabetes completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jaeb Center for Health Research | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2017-10-23